ANCA-Associated Vasculitis: The Pulmonologist’s Role in Diagnosis, Treatment and Management
Image For Activity Cover
Expires on Oct 25, 2024
Credit Offered
1.25 CME / CE Credits
1.25 MOC Points
1.25 RN Credits
1.25 PA Credits
1.25 AANPCB Credits
In this CME-certified symposium, top CHEST experts focus on ANCA-associated vasculitis (AAV), including its symptoms, etiology, diagnostic process, and currently approved treatments. The faculty also discuss specific patient cases.
  1. Recognize the burden of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) on patient quality of life. 
  2. Identify the role of the complement alternative pathway in the pathogenesis and treatment of GPA/MPA.
  3. Use appropriate tools and guidelines to identify patients with GPA/MPA in a timely and accurate manner.
  4. Outline the magnitude and significance of glucocorticoid toxicity in GPA/MPA management.
  5. Summarize the latest clinical evidence for current and emerging treatments for patients with GPA/MPA.
  6. Apply updated treatment guidelines to assist clinical decision making for patients with GPA/MPA.
  7. Examine interprofessional strategies to improve care and outcomes of patients with GPA/MPA.
This activity is supported by an educational grant from Amgen, Inc.

© 2024 | American College of Chest Physicians®

Android App Download IOS App Download Powered By